Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chengappa, Roy
APTS, NCT04887792: Acetazolamide for Treatment Resistant Schizophrenia	Recruiting	1/2	60	US, RoW	Acetazolamide, Diamox, Placebo	Vishwajit Nimgaonkar, MD PhD, Stanley Medical Research Institute	Schizophrenia, Schizo Affective Disorder	01/25	10/25